The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Neutrophils in Cancer: Two Sides of the Same Coin
Open accessAbstract
Neutrophils are the most abundant leukocytes in blood and are considered to be the first line of defense during inflammation and infections. In addition, neutrophils are also found infiltrating many types of tumors. Tumor-associated neutrophils (TANs) have relevant roles in malignant disease. Indeed neutrophils may be potent antitumor effector cells. However, increasing clinical evidence shows TANs correlate with poor prognosis. The tumor microenvironment controls neutrophil recruitment and in turn TANs help tumor progression. Hence, TANs can be beneficial or detrimental to the host. It is the purpose of this review to highlight these two sides of the neutrophil coin in cancer and to describe recent studies that provide some light on the mechanisms for neutrophil recruitment to the tumor, for neutrophils supporting tumor progression, and for neutrophil activation to enhance their antitumor functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–209 of 209
Nawa, M., Osada, S., Morimitsu, K., Nonaka, K., Futamura, M., Kawaguchi, Y., & Yoshida, K. (2012) · PubMed · Cited by 30
FcR γ-Chain Dependent Signaling in Immature Neutrophils Is Mediated by FcαRI, but Not by FcγRI
Otten, M. A., Leusen, J. H. W., Rudolph, E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2918 · Cited by 28
Neutrophil Elastase Inhibitor Reduces Hepatic Metastases Induced by Ischaemia-Reperfusion in Rats
Doi, K., Horiuchi, T., Uchinami, M., Tabo, T., Kimura, N., Yokomachi, J., Yoshida, M., & Tanaka, K. (2002) · The European Journal of Surgery · doi:10.1080/110241502321116541 · Cited by 28
García-García, E., Uribe‐Querol, E., & Rosales, C. (2013) · Journal of Visualized Experiments · doi:10.3791/50410 · Cited by 26
Self-citationAntibody - Fc Receptor Interactions in Antimicrobial Functions
Rosales, C., & Uribe‐Querol, E. (2013) · Current Immunology Reviews · doi:10.2174/1573395511309010006 · Cited by 26
Self-citationDerer, S., Kellner, C., Berger, S., Valerius, T., & Peipp, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-974-7_30 · Cited by 20
Matsushima, A., Ogura, H., Koh, T., Fujita, K., Yoshiya, K., Sumi, Y., Hosotsubo, H., Kuwagata, Y., Tanaka, H., Shimazu, T., et al. (2004) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000111752.60500.da · Cited by 15
Standard therapies versus novel therapies in Hodgkin lymphoma
Gallamini, A., Raimondo, F. D., Nasa, G. L., Romano, A., Borra, A., & Greco, M. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.09.011 · Cited by 13
Fcγ Receptor Polymorphisms as Biomarkers for Epidermal Growth Factor Receptor Antibodies
Valerius, T. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7342 · Cited by 7
Cited by
The Tumor Microenvironment Innately Modulates Cancer Progression
Hinshaw, D. C., & Shevde, L. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3962 · Cited by 3,270
Lei, X., Lei, Y., Li, J.-K., Du, W.-X., Li, R.-G., Yang, J., Li, J., Li, F., & Tan, H.-B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.009 · Cited by 1,470
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
Self-citationThe Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Masucci, M. T., Minopoli, M., & Carriero, M. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01146 · Cited by 649
Metadata
- Authors
- Uribe-Querol, E., & Rosales, C.
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-21
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- OpenAlex
- W2214799754
- Cited by
- 422
- References
- 209
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.